HistoSonics

HistoSonics is a medical device company developing non-invasive platforms and proprietary sonic beam therapy using histotripsy. Histotripsy is a focused ultrasound technology that mechanically destroys and liquefies unwanted tissue and tumors. The company is focused on commercializing their Edison System for liver treatment and expanding into other organs.


Buy Funded Startups lists

Funding Round: Series D

Funding Amount: $102M

Date: 15-Aug-2024

Investors: Alpha Wave Ventures, Amzak Health, HealthQuest Capital, Johnson & Johnson Innovation - JJDC, Inc. (JJDC), Venture Investors, Lumira Ventures, Yonjin Venture, the State of Wisconsin Investment Board

Markets: Medical Device, Healthtech, Ultrasound, Surgical Devices, Other Healthcare Services, Oncology

HQ: Plymouth, Minnesota, United States

Founded: 2009

Website: https://www.histosonics.com/

LinkedIn: https://www.linkedin.com/company/histosonics-inc-

Twitter: https://twitter.com/histosonics

Instagram:

Facebook: https://www.facebook.com/pages/Histosonics/148367665878420

Crunchbase: https://www.crunchbase.com/organization/histosonics

Pitchbook: https://pitchbook.com/profiles/company/53875-81


Leave a Comment